Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2013 Dicembre;55(4) > Panminerva Medica 2013 Dicembre;55(4):311-26

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

PANMINERVA MEDICA

Rivista di Medicina Interna


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6


eTOC

 

  PERCUTANEOUS CORONARY AND VASCULAR INTERVENTIONS


Panminerva Medica 2013 Dicembre;55(4):311-26

lingua: Inglese

Management of multivessel coronary artery disease

Parikh P. B., Kirtane A. J., Moses J. W.

Division of Cardiology, Department of Medicine Columbia University Medical Center/New York, Presbyterian Hospital, New York, NY, USA


PDF  


Optimal management of multivessel disease (MVD) is a complex medical decision with significant prognostic implications. Despite the advent of clinical and angiographic scores to aid with treatment delineation, therapy for MVD must be individualized for each patient and his/her clinical presentation. Particularly among patients with MVD, the selection of coronary revascularization with percutaneous coronary intervention versus coronary artery bypass graft surgery versus guideline-directed medical therapy (GDMT) alone is a prognostically important decision. Several patient factors including clinical presentation, severity of coronary artery disease, presence of left ventricular dysfunction and other comorbidities, and the patient’s personal preferences should guide the decision making process. In this review, we discuss the management of MVD with regards to decisions of revascularization versus GDMT alone, mode of revascularization, extent of revascularization (i.e., complete versus incomplete), the strategy of angiography- versus ischemia-guided revascularization, and MVD management in the setting of an acute coronary syndrome.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

jm2456@columbia.edu